United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Oct 7, 2026 · Filed Oct 8, 2026

On Oct 7, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$548.95 for US$5.22M under a trading plan, leaving 324,443 shares. Filed Oct 8, 2026 (Form 4).

Sold
9,500 shares
Price
US$548.95 average (US$542.73 to US$556.48)
Value
US$5.22M
Holding after
324,443 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Oct 7, 2026Common StockOption exercise9,500US$117.76333,943Indirect
Oct 7, 2026Common StockSale176US$542.73333,767Indirect
Oct 7, 2026Common StockSale744US$543.76333,023Indirect
Oct 7, 2026Common StockSale2,098US$544.82330,925Indirect
Oct 7, 2026Common StockSale493US$545.85330,432Indirect
Oct 7, 2026Common StockSale629US$546.94329,803Indirect
Oct 7, 2026Common StockSale387US$548.18329,416Indirect
Oct 7, 2026Common StockSale1,173US$549.13328,243Indirect
Oct 7, 2026Common StockSale874US$550.14327,369Indirect
Oct 7, 2026Common StockSale486US$551.09326,883Indirect
Oct 7, 2026Common StockSale440US$552.29326,443Indirect
Oct 7, 2026Common StockSale185US$553.70326,258Indirect
Oct 7, 2026Common StockSale485US$554.51325,773Indirect
Oct 7, 2026Common StockSale930US$555.77324,843Indirect
Oct 7, 2026Common StockSale400US$556.48324,443Indirect

Source

View original at SEC

Related